Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER
Vaccine, (2017). 35:3295-3302

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER
Vaccine, (2017). 35:3303-3308

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.Nyiro JU, Sande C, Mutunga M, Kiyuka PK, Munywoki PK, Scott JA, Nokes DJ
Vaccine, (2015). 33:1797-801

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, Henao-Restrepo AM, Leach AJ, Klugman KP, Porter BD, Sa-Leao R, Scott JA, Nohynek H, O'Brien KL, WHO Pneumococcal Carriage Working Group
Vaccine, (2013). 32:165-79

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?.Moisi JC, Kabuka J, Mitingi D, Levine OS, Scott JA
Vaccine, (2010). 28:5725-30

The preventable burden of pneumococcal disease in the developing world.Scott JA
Vaccine, (2007). 25:2398-405